生物
内皮干细胞
下调和上调
发病机制
细胞生物学
PI3K/AKT/mTOR通路
内皮功能障碍
血管内皮生长因子B
癌症研究
基因表达谱
内皮
血管生成
信号转导
病理
转录组
基因表达
载脂蛋白B
免疫学
小桶
血管内皮生长因子A
基因
细胞
表型
基因剔除小鼠
基因表达调控
基因表达的系列分析
生物信息学
作者
向羿,Dong Liu,Wenwen Jin,Tao Xu,Leilei Guo,Tingchun Wu,Yuhua Zheng,Xiaoman Xiong,Haixia Xiong,Hua He
出处
期刊:Cell Cycle
[Taylor & Francis]
日期:2026-06-28
卷期号:25 (1): 1-20
标识
DOI:10.1080/15384101.2026.2688663
摘要
Vascular endothelial dysfunction plays a critical role in the development of atherosclerosis; however, the mechanisms by which endothelial cells contribute to plaque instability remain incompletely understood. In this study, we performed an integrated analysis of single-cell RNA sequencing (scRNA-seq) and bulk RNA-seq data to characterize endothelial cell heterogeneity associated with carotid plaque instability. Clustering analysis, gene set variation analysis (GSVA), differential gene expression analysis, and KEGG pathway enrichment were conducted to identify key endothelial cell subsets and their functional characteristics. We identified three endothelial cell subsets (subsets 9, 10, and 11) that were significantly enriched in unstable plaques and exhibited upregulation of multiple pro-inflammatory cytokines. Pathway analysis revealed that these subsets were associated with activation of the PI3K – Akt signaling pathway and other inflammation-related pathways. Furthermore, findings were validated in an apolipoprotein E-deficient (ApoE−/−) mouse model, where increased expression of placental growth factor (PGF) and a higher proportion of PGF-positive endothelial cells were observed in atherosclerotic lesions. In conclusion, this study reveals the heterogeneity of endothelial cells in atherosclerotic plaques and identifies pro-inflammatory endothelial subsets potentially associated with plaque instability, providing new insights into the pathogenesis of atherosclerosis.Trial registration: This study was approved by the Experimental Animal Ethics Committee of Guizhou University of Chinese Medicine (approval number: 2,024,010).
科研通智能强力驱动
Strongly Powered by AbleSci AI